Mindray's shareholder resolutions adopted at annual general meeting

Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28, 2015.

At the meeting, Mindray shareholders voted to re-elect incumbent director, chairman of board Xu Hang and director Ronald Ede, each to serve a three-year term.

In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2015.

Source:

Mindray Medical International Limited

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mindray. (2019, June 19). Mindray's shareholder resolutions adopted at annual general meeting. News-Medical. Retrieved on August 06, 2020 from https://www.news-medical.net/news/20151230/Mindrays-shareholder-resolutions-adopted-at-annual-general-meeting.aspx.

  • MLA

    Mindray. "Mindray's shareholder resolutions adopted at annual general meeting". News-Medical. 06 August 2020. <https://www.news-medical.net/news/20151230/Mindrays-shareholder-resolutions-adopted-at-annual-general-meeting.aspx>.

  • Chicago

    Mindray. "Mindray's shareholder resolutions adopted at annual general meeting". News-Medical. https://www.news-medical.net/news/20151230/Mindrays-shareholder-resolutions-adopted-at-annual-general-meeting.aspx. (accessed August 06, 2020).

  • Harvard

    Mindray. 2019. Mindray's shareholder resolutions adopted at annual general meeting. News-Medical, viewed 06 August 2020, https://www.news-medical.net/news/20151230/Mindrays-shareholder-resolutions-adopted-at-annual-general-meeting.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Mindray Medical announces completion of Wuhan Dragonbio acquisition